Updates

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I

Dec 28, 2021

Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART II

Dec 28, 2021

Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART III

Dec 28, 2021

Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual Read More

DOSE OF REALITY: OVERSIGHT REPORT EXPOSES BIG PHARMA’S EGREGIOUS PRICING & ANTI-COMPETITIVE TACTICS — DEBUNKS INNOVATION RHETORIC

Dec 12, 2021

Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top Read More

CSRXP: LANDMARK OVERSIGHT REPORT DEBUNKS BIG PHARMA’S FALSE RHETORIC, ADDS TO MOMENTUM TO LOWER RX PRICES

Dec 10, 2021

U.S. House Oversight & Reform Committee Report Finds Big Pharma’s Read More

SECOND OPINION: BIG PHARMA DOUBLES DOWN ON BLAME GAME STRATEGY AMID UNPRECEDENTED MOMENTUM TO LOWER RX PRICES

Dec 3, 2021

New PhRMA Ad Campaign Aims to Dodge Accountability, Push Pharma-Backed Rebate Read More

BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN BRAND NAME DRUGS COST U.S. $1.6 BILLION IN 2020

Nov 16, 2021

New Analysis Underscores How Big Pharma’s Price Increases Cost The American Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

Nov 15, 2021

AstraZeneca’s Q3 Earnings Report Shows Pandemic Price Hikes Profitable for Read More

CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS

Nov 12, 2021

Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Read More

BIG PHARMA EARNINGS WATCH: SANOFI, ABBVIE, PFIZER & AMGEN

Nov 9, 2021

New Round of Q3 Earnings Reports Continue to Show Big Pharma Profits Buoyed By Read More

BIG PHARMA WATCH: BIG PHARMA SPENDS $263M ON LOBBYING, CAMPAIGN DONATIONS FIGHTING SOLUTIONS TO LOWER RX PRICES

Nov 4, 2021

New Analysis Highlights How Big Pharma Uses Limitless Resources Read More